Erlotinib for Hepatocellular Carcinoma Chemoprevention
Condition: Cirrhosis, Liver Intervention: Drug: Erlotinib Hydrochloride Sponsor: University of Texas Southwestern Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Hepatocellular Carcinoma | Liver | Liver Cancer | Research | Tarceva | Urology & Nephrology